OCT 11, 2026 · JOURNAL ARTICLE
Modern possibilities of antiviral therapy for chronic viral hepatitis C in children aged 3 to 17 in the Moscow Region
Children Infections
Aim to evaluate the effectiveness and safety of of glecaprevir/pibrentasvir (GLE/PIB) in two dosage forms and velpatosvir/sofosbuvir (VEL/SOF) in children 317 years old with chroni